RECURRENT THYMOMA

Clinical trials for RECURRENT THYMOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT THYMOMA trials appear

Sign up with your email to follow new studies for RECURRENT THYMOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New Two-Pronged drug tested for rare thymus cancers

Disease control Ongoing

This study is testing an experimental drug called bintrafusp alfa (M7824) for people with thymoma or thymic carcinoma that has returned or worsened after standard platinum-based chemotherapy. The drug is designed to work in two ways: by blocking a protein that helps tumors hide f…

Matched conditions: RECURRENT THYMOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 18:41 UTC

RECURRENT THYMOMA

Get alerted when new RECURRENT THYMOMA trials appear

New Two-Pronged drug tested for rare thymus cancers